1960s-- MDPV was developed for treatment of chronic fatigue, but caused problems of abuse and dependence. 1969: Boehringer Ingelheim filed a patent application for MDPV. 2005: MDPV first appeared as recreational drug.
2007: First seizure of MDPV as a recreational drug, by customs officials in German state of Saxony. 2008: First seizure of MDPV in the United States.
2009: MDPV became illegal in Denmark.
2010: MDPV made a controlled drug in the UK, Sweden, Germany, Australia and Finland. First reports of the widespread retail marketing of 'bath salts' containing MDPV in the U.S. The US recognizes both Mephedrone (July, 2010) and MDPV (December, 2010) "a drug and chemical of concern". 2011: MDPV sale and possession are banned in Alabama, Arkansas, Delaware, Florida, Georgia, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Mississippi, New Jersey, New Mexico, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Tennessee, Utah, Virginia, Washington State (as of November 3, 2011), West Virginia, Wisconsin and Wyoming, with legislation being introduced in many other states. The DEA moved to temporarily ban MDPV, Mephedrone and Methylone on October 21, 2011 2012: Permanent U.S. ban is imminent on few, select chemicals. In 2012 the Congress passed the Food and Drug Administration Safety and Innovation Act—Synthetic Drugs which will list MDPV and Mephedrone, but not Methylone.
"Bath Salts" are man made products of naturally occurring drugs, created and made popular by "armchair chemists" encouraged by profit potential and whose business insight is much more developed than their chemistry abilities. MDPV is a legal stimulant who's chemical name is Methylenedioxypyrovalerone, the active ingredient in "Bath Salts". Mephedrone, is a synthetic drug of the amphetamine class. Although the drug is not related to actual bath salts, it’s sometimes sold under the label. It is made from various amphetamine-like chemicals, and can be...
Please join StudyMode to read the full document